Showing results (601-610 of 1,006) with videos related to

Sort By:
Pageof 101
Cardiovascular Therapeutics|September 3, 2011
A dosing algorithm for erythropoietin alpha in older adults with heart failure and a preserved ejection fractionArman Altincatal, Robert B Macarthur, Sergio Teruya, et al.
Cardiovascular Therapeutics|December 6, 2011
Novel effects of macrolide antibiotics on cardiovascular diseasesJun-ichi Suzuki, Masahito Ogawa, Keiichi Hishikari, et al.
Cardiovascular Therapeutics|October 7, 2011
Glycoprotein IIb-IIIa inhibitorsGiuseppe De Luca
Cardiovascular Therapeutics|January 28, 2012
Cardio-selective beta-blocker: pharmacological evidence and their influence on exercise capacityDennis Ladage, Robert H G Schwinger, Klara Brixius
Cardiovascular Therapeutics|January 28, 2012
Opportunity nox: the future of NADPH oxidases as therapeutic targets in cardiovascular diseaseJennifer Streeter, William Thiel, Kate Brieger, et al.
Cardiovascular Therapeutics|October 17, 2014
Effect of nicorandil in patients with heart failure: a systematic review and meta-analysisFujie Zhao, Sandip Chaugai, Peng Chen, et al.
Cardiovascular Therapeutics|December 11, 2019
Role and Effective Therapeutic Target of Gut Microbiota in Heart FailureQiujin Jia, Hao Li, Huan Zhou, et al.
Cardiovascular Therapeutics|February 27, 2020
Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature ReviewRupert Bauersachs, Uwe Zeymer, Jean-Baptiste Brière, et al.
Cardiovascular Therapeutics|March 13, 2020
Hyperuricemia is a Risk Factor for One-Year Overall Survival in Elderly Female Patients with Acute Coronary SyndromeShi Tai, Xuping Li, Zhaowei Zhu, et al.
Pageof 101